Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Código QR

Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Ling-ling Zhu,1 Zhi-jun Feng,2 Quan Zhou3 1Geriatric VIP Ward, Division of Nursing, 2Department of Urology Surgery, 3Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China We read with great i...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhu LL, Feng ZJ, Zhou Q
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	benign prostatic hyperplasia α1-blockers personalized therapeutics Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/6db82784acbc448ab65276f3af05e013
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
por: D Gnyawali, et al.
Publicado: (2016)

The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom
por: Yang L, et al.
Publicado: (2021)

Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
por: Wang XY, et al.
Publicado: (2016)

Urinary Tract Stones Risk Factors in Patients with Benign Prostatic Hyperplasia in West Java, Indonesia
por: Iman Surendroputro Tjahjodjati, et al.
Publicado: (2021)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
por: Lee WC, et al.
Publicado: (2013)

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia
por: Shao IH, et al.
Publicado: (2013)

Relationship between Dietary Patterns with Benign Prostatic Hyperplasia and Erectile Dysfunction: A Collaborative Review
por: Giorgio Ivan Russo, et al.
Publicado: (2021)

Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial
por: Amr Fawzi, et al.
Publicado: (2017)

Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
por: Zhang LT, et al.
Publicado: (2015)

Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
por: Grzesiak K, et al.
Publicado: (2018)

Incidence and Risk Factors of Post-Operative Depression in Patients Undergoing Transurethral Resection of Prostate for Benign Prostatic Hyperplasia
por: Zhu D, et al.
Publicado: (2021)

A systematic review of herbal medicine in the clinical treatment of benign prostatic hyperplasia
por: Kristian Leisegang, et al.
Publicado: (2022)

Comparison of the Efficacy and Safety of Minimally Invasive Simple Prostatectomy and Endoscopic Enucleation of Prostate for Large Benign Prostatic Hyperplasia
por: Jinze Li, et al.
Publicado: (2021)

Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system
por: McNicholas TA
Publicado: (2016)

Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
por: McVary KT, et al.
Publicado: (2021)

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
por: Claus G Roehrborn, et al.
Publicado: (2008)

Correlation of Detrusor Wall Thickness with International Prostate Symptom Score: A Cross-sectional Study of Nigerian Men with Prostate-Related Diseases
por: OBASI AUGUSTINE ULEBE, et al.
Publicado: (2021)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
por: Allameh F, et al.
Publicado: (2020)

ROLE OF COMBINED KETOCONAZOLE AND TAMSULOSIN IN SUCCESSFUL TRIAL OF VOIDING WITHOUT CATHETER (TWOC) IN PATIENTS WITH ACUTE URINARY RETENTION DUE TO BENIGN PROSTATIC OBSTRUCTION
por: Muhammad Asim, et al.
Publicado: (2020)

Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats
por: Al-Trad B, et al.
Publicado: (2019)

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial
por: Shin YS, et al.
Publicado: (2016)

Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
por: Fatemeh Khatami, et al.
Publicado: (2020)

Influence of р-thyrozol on the morphology and antioxidant-prooxidant balance in prostate of rats at sulpiride-induced benign prostatic hyperplasia
por: T. G. Borovskaya, et al.
Publicado: (2014)

Comparative Evaluation of Post-TURP Complications in Patients with BPH Presenting with and Without Acute Urinary Retention
por: Veda Murthy Reddy Pogula, et al.
Publicado: (2021)

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin
por: Yang PS, et al.
Publicado: (2018)

Research on Applications of Transurethral Plasmakinetic Enucleation of the Prostate in Elderly Patients Aged ≥80 Years
por: Wen Su, et al.
Publicado: (2021)

Twelve-week, prospective, open-label, randomized trial on the effects of an anticholinergic agent or antidiuretic agent as add-on therapy to an alpha-blocker for lower urinary tract symptoms
por: Shin YS, et al.
Publicado: (2014)

Perspective on the Rezūm® System: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy
por: Woo HH, et al.
Publicado: (2017)

Evaluation of ‘Visual prostate symptom score’ in men with benign enlargement of prostate in a tertiary care center in midwestern Nepal
por: Dipesh Kumar Gupta
Publicado: (2017)

EFFECT OF DUTASTERIDE IN DECREASING SURGICAL BLOOD LOSS FOLLOWING UNIPOLAR TRANSURETHRAL RESECTION OF PROSTATEIN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: A QUASI EXPERIMENTAL STUDY
por: Mujahid Ali Khoso, et al.
Publicado: (2019)

Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery
por: Hou CP, et al.
Publicado: (2013)

The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis
por: Shaun Wen Huey Lee, et al.
Publicado: (2017)

Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA
por: Maurizia Mello-Grand, et al.
Publicado: (2021)

Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation
por: Petra Popovics, et al.
Publicado: (2021)

High degree of prostate related LUTS in a prospective cross-sectional community study in Ghana (Mamprobi)
por: George A. Asare, et al.
Publicado: (2021)

Identificación de factor de crecimiento vascular endotelial en células glandulares de tejido prostético maligno y benigno: Relación con la recidiva tumoral al año de la prostatectomía
por: Acuña,Pedro, et al.
Publicado: (2013)

Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study
por: Lin YH, et al.
Publicado: (2017)

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
por: Yoshida M, et al.
Publicado: (2011)

Prostate Artery Embolization—Review of Indications, Patient Selection, Techniques and Results
por: Sailendra G. Naidu, et al.
Publicado: (2021)

High Concentration of Reticular Fibers in Periurethral Region of the Prostatic Urethra from Patients with Benign Prostatic Hyperplasia as Revealed by Stereology
por: Manaia,Jorge H. M, et al.
Publicado: (2012)